Antibiotics Aren’t Profitable Enough for Big Pharma to Make More

  10 May 2019

Public health experts are calling for new incentives to reward companies for bringing drugs that are effective against resistant strains to market.

Further reading: Bloomberg
Smart Innovations  
Back


Display your AMR technology / product:

Global AMR Technologies Database

  • Preventive – Diagnostic – Antimicrobial technologies
  • Academia – Research Institutes – Start ups – SMEs – Multinationals
  • Early research <-> near market
  • Global reach for funding / co-development / licensing
Display your technology and make use of the Continuous AMR Partnering Initiative >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!